Radiance Therapeutics

Tucson, United States

Radiance Therapeutics is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.

Dec 2023

Convertible Note

Biotechnology Health Care Medical Therapeutics

Top Investors

FIVESTAR Capital Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Radiance Therapeutics

Who are Radiance Therapeutics's investors?

Radiance Therapeutics's investors include FIVESTAR Capital Partners.

Where is Radiance Therapeutics headquartered?

Radiance Therapeutics is headquartered in Tucson, United States.

What does Radiance Therapeutics do?

Radiance Therapeutics is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.

What stage is Radiance Therapeutics at?

Radiance Therapeutics is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 5, 2023.

MLA

"Radiance Therapeutics — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/radiance-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Radiance Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/radiance-therapeutics

Wikipedia (cite web)

{{cite web |title=Radiance Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/radiance-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 5, 2023.